Susquehanna Issues Pessimistic Forecast for RXO (NYSE:RXO) Stock Price

RXO (NYSE:RXOFree Report) had its price target reduced by Susquehanna from $16.00 to $12.00 in a research note published on Tuesday,Benzinga reports. They currently have a negative rating on the stock.

Several other research analysts have also recently weighed in on RXO. Benchmark restated a “hold” rating on shares of RXO in a report on Tuesday, October 15th. Jefferies Financial Group dropped their target price on RXO from $33.00 to $31.00 and set a “buy” rating for the company in a report on Tuesday, August 13th. JPMorgan Chase & Co. lifted their price target on RXO from $25.00 to $26.00 and gave the stock an “underweight” rating in a report on Thursday, August 8th. TD Cowen upped their price objective on shares of RXO from $23.00 to $28.00 and gave the company a “hold” rating in a report on Thursday, August 8th. Finally, Citigroup cut shares of RXO from a “buy” rating to a “neutral” rating and set a $33.00 price objective for the company. in a research report on Tuesday. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $26.29.

Check Out Our Latest Stock Report on RXO

RXO Trading Down 0.9 %

Shares of RXO stock opened at $27.25 on Tuesday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.33 and a quick ratio of 1.33. The company has a market cap of $4.38 billion, a price-to-earnings ratio of -13.76, a PEG ratio of 15.00 and a beta of 1.33. RXO has a 1-year low of $18.75 and a 1-year high of $32.82. The stock has a 50 day simple moving average of $27.85 and a 200-day simple moving average of $26.04.

RXO (NYSE:RXOGet Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. The firm had revenue of $1.04 billion for the quarter, compared to analyst estimates of $956.19 million. RXO had a positive return on equity of 1.64% and a negative net margin of 6.81%. The business’s revenue was up 6.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.05 earnings per share. On average, equities research analysts expect that RXO will post 0.12 EPS for the current fiscal year.

Institutional Trading of RXO

Several hedge funds have recently made changes to their positions in RXO. Geode Capital Management LLC increased its stake in RXO by 16.9% during the 3rd quarter. Geode Capital Management LLC now owns 3,055,229 shares of the company’s stock worth $85,563,000 after buying an additional 441,994 shares during the period. Barclays PLC raised its stake in RXO by 185.5% in the third quarter. Barclays PLC now owns 908,873 shares of the company’s stock valued at $25,449,000 after buying an additional 590,530 shares in the last quarter. Nomura Asset Management Co. Ltd. lifted its holdings in RXO by 68.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock worth $39,000 after buying an additional 570 shares during the last quarter. Zimmer Partners LP acquired a new position in shares of RXO during the 3rd quarter worth about $22,680,000. Finally, Wolverine Trading LLC purchased a new position in shares of RXO in the 3rd quarter valued at about $233,000. Institutional investors and hedge funds own 92.73% of the company’s stock.

RXO Company Profile

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Read More

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.